Showing results (211-220 of 1,918) with videos related to
Sort By:
Pageof 192
Current Drug Metabolism|May 20, 2017
Mirna Expression in Bladder Cancer and Their Potential Role in Clinical PracticeAna Blanca, Liang Cheng, Rodolfo Montironi, et al.Current Drug Metabolism|March 11, 2010
Therapeutic nanoparticles to combat cancer drug resistanceChe-Ming Jack Hu, Liangfang ZhangCurrent Drug Metabolism|March 11, 2010
Nanotechology-based strategies to enhance the efficacy of photodynamic therapy for cancersWen-Tyng LiCurrent Drug Metabolism|March 11, 2010
Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infectionsPei-Feng Liu, Chih-Wei Lo, Chao-Hsuan Chen, et al.Current Drug Metabolism|March 11, 2010
Pharmacogenomics in drug induced liver injuryRaúl J Andrade, José A G Agúndez, M Isabel Lucena, et al.Current Drug Metabolism|March 11, 2010
On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevanceDirk P Van Asseldonk, Nanne K H de Boer, Godefridus J Peters, et al.Current Drug Metabolism|March 11, 2010
Pharmacogenomics in aspirin intoleranceJosé A G Agúndez, Carmen Martínez, Dolores Pérez-Sala, et al.Current Drug Metabolism|May 24, 2018
Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Taxus-based Drug DevelopmentDa-Cheng Hao, Guang-Bo Ge, Ping Wang, et al.Current Drug Metabolism|May 29, 2018
A Review on the Expression and Metabolic Features of Orphan Human Cytochrome P450 2S1 (CYP2S1)Pan Yan, Ong Chin Eng, Chieng Jin YuCurrent Drug Metabolism|May 12, 2018
Polysaccharide Nanoparticles for Targeted Cancer TherapiesPeipei Peng, Ke Yang, Gangsheng Tong, et al.Pageof 192